vs
波士顿科学(MLSS)与Palladyne AI Corp.(PDYN)财务数据对比。点击上方公司名可切换其他公司
波士顿科学的季度营收约是Palladyne AI Corp.的1.2倍($2.1M vs $1.7M),波士顿科学净利率更高(-53.0% vs -89.9%,领先36.9%),Palladyne AI Corp.同比增速更快(118.3% vs 2.2%),过去两年波士顿科学的营收复合增速更高(-4.3% vs -30.5%)
波士顿科学公司是源自美国的跨国生物医疗企业,专业研发生产介入医疗领域医疗器械,产品覆盖介入放射学、介入心脏病学、外周介入治疗、神经调控、神经血管介入、电生理、心脏外科、血管外科、内镜、肿瘤学、泌尿与妇科等多个领域。
Palladyne AI Corp是一家美国企业,其前身1983年成立时名为萨科斯研究公司,企业长期以来以机器人开发为核心业务。2023年,公司调整业务方向,专注开发适用于机器人场景的人工智能软件,终止了硬件业务,并于2024年3月正式更名为现用名。
MLSS vs PDYN — 直观对比
营收规模更大
MLSS
是对方的1.2倍
$1.7M
营收增速更快
PDYN
高出116.1%
2.2%
净利率更高
MLSS
高出36.9%
-89.9%
两年增速更快
MLSS
近两年复合增速
-30.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $2.1M | $1.7M |
| 净利润 | $-1.1M | $-1.5M |
| 毛利率 | 73.0% | 15.6% |
| 营业利润率 | -52.5% | -560.7% |
| 净利率 | -53.0% | -89.9% |
| 营收同比 | 2.2% | 118.3% |
| 净利润同比 | 46.4% | 97.2% |
| 每股收益(稀释后) | — | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
MLSS
PDYN
| Q4 25 | $2.1M | $1.7M | ||
| Q3 25 | $2.4M | $860.0K | ||
| Q2 25 | $2.3M | $1.0M | ||
| Q1 25 | $2.2M | $1.7M | ||
| Q4 24 | $2.0M | $761.0K | ||
| Q3 24 | $2.5M | $871.0K | ||
| Q2 24 | $1.9M | $2.7M | ||
| Q1 24 | $2.2M | $3.4M |
净利润
MLSS
PDYN
| Q4 25 | $-1.1M | $-1.5M | ||
| Q3 25 | $-1.2M | $-3.7M | ||
| Q2 25 | $-1.5M | $-7.5M | ||
| Q1 25 | $-2.0M | $22.8M | ||
| Q4 24 | $-2.0M | — | ||
| Q3 24 | $-1.5M | $-7.1M | ||
| Q2 24 | $223.6K | $-5.3M | ||
| Q1 24 | $-1.4M | $-7.2M |
毛利率
MLSS
PDYN
| Q4 25 | 73.0% | 15.6% | ||
| Q3 25 | 69.5% | 46.4% | ||
| Q2 25 | 69.6% | 53.3% | ||
| Q1 25 | 73.8% | 79.4% | ||
| Q4 24 | 75.0% | 27.2% | ||
| Q3 24 | 73.0% | 45.0% | ||
| Q2 24 | 76.1% | 79.0% | ||
| Q1 24 | 74.5% | 45.2% |
营业利润率
MLSS
PDYN
| Q4 25 | -52.5% | -560.7% | ||
| Q3 25 | -48.1% | -937.8% | ||
| Q2 25 | -63.9% | -797.4% | ||
| Q1 25 | -89.5% | -405.3% | ||
| Q4 24 | -101.4% | — | ||
| Q3 24 | -58.4% | -838.0% | ||
| Q2 24 | -96.0% | -213.3% | ||
| Q1 24 | -65.1% | -213.7% |
净利率
MLSS
PDYN
| Q4 25 | -53.0% | -89.9% | ||
| Q3 25 | -48.9% | -434.9% | ||
| Q2 25 | -63.8% | -737.6% | ||
| Q1 25 | -89.3% | 1330.9% | ||
| Q4 24 | -101.1% | — | ||
| Q3 24 | -58.1% | -814.7% | ||
| Q2 24 | 12.1% | -196.2% | ||
| Q1 24 | -64.1% | -210.1% |
每股收益(稀释后)
MLSS
PDYN
| Q4 25 | — | $-0.02 | ||
| Q3 25 | $-0.01 | $-0.09 | ||
| Q2 25 | — | $-0.20 | ||
| Q1 25 | — | $0.55 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.02 | $-0.27 | ||
| Q2 24 | — | $-0.20 | ||
| Q1 24 | — | $-0.28 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.1M | $47.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.8M | $74.7M |
| 总资产 | $7.8M | $95.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
MLSS
PDYN
| Q4 25 | $1.1M | $47.1M | ||
| Q3 25 | $1.3M | $57.1M | ||
| Q2 25 | $1.3M | $62.7M | ||
| Q1 25 | $2.2M | $46.6M | ||
| Q4 24 | $3.3M | $40.1M | ||
| Q3 24 | $4.8M | $21.3M | ||
| Q2 24 | $5.8M | $25.8M | ||
| Q1 24 | $5.0M | $31.8M |
股东权益
MLSS
PDYN
| Q4 25 | $2.8M | $74.7M | ||
| Q3 25 | $2.5M | $51.8M | ||
| Q2 25 | $3.3M | $53.8M | ||
| Q1 25 | $4.5M | $28.3M | ||
| Q4 24 | $5.8M | $-9.5M | ||
| Q3 24 | $7.2M | $23.4M | ||
| Q2 24 | $8.0M | $29.8M | ||
| Q1 24 | $7.5M | $34.2M |
总资产
MLSS
PDYN
| Q4 25 | $7.8M | $95.7M | ||
| Q3 25 | $8.5M | $72.9M | ||
| Q2 25 | $8.1M | $78.3M | ||
| Q1 25 | $9.1M | $63.3M | ||
| Q4 24 | $9.8M | $56.3M | ||
| Q3 24 | $11.2M | $38.7M | ||
| Q2 24 | $12.0M | $45.1M | ||
| Q1 24 | $11.4M | $50.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-226.1K | $-8.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-8.7M |
| 自由现金流率自由现金流/营收 | — | -526.2% |
| 资本支出强度资本支出/营收 | — | 14.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
MLSS
PDYN
| Q4 25 | $-226.1K | $-8.5M | ||
| Q3 25 | $81.8K | $-6.3M | ||
| Q2 25 | $-1.8M | $-5.3M | ||
| Q1 25 | $-1.0M | $-7.5M | ||
| Q4 24 | $-1.5M | $-22.6M | ||
| Q3 24 | $-973.9K | $-4.5M | ||
| Q2 24 | $783.7K | $-5.8M | ||
| Q1 24 | $-1.2M | $-7.2M |
自由现金流
MLSS
PDYN
| Q4 25 | — | $-8.7M | ||
| Q3 25 | — | $-6.7M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-7.6M | ||
| Q4 24 | — | $-22.9M | ||
| Q3 24 | — | $-4.5M | ||
| Q2 24 | — | $-5.9M | ||
| Q1 24 | — | $-7.3M |
自由现金流率
MLSS
PDYN
| Q4 25 | — | -526.2% | ||
| Q3 25 | — | -776.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -445.0% | ||
| Q4 24 | — | -3008.1% | ||
| Q3 24 | — | -517.8% | ||
| Q2 24 | — | -218.9% | ||
| Q1 24 | — | -212.1% |
资本支出强度
MLSS
PDYN
| Q4 25 | — | 14.2% | ||
| Q3 25 | — | 44.7% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 5.4% | ||
| Q4 24 | — | 34.8% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | 5.3% | ||
| Q1 24 | — | 1.8% |
现金转化率
MLSS
PDYN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.33× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.50× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图